Octarine Bio

Series-A
octarinebio.com Biotech & Healthcare
Total Funding $10.2M
Latest Round $5.8M Series-A
Last Announced Apr 29, 2026
Investors Undisclosed
Decision Makers Profile Active

About Octarine Bio

Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 6, 2026

Web & Domain Identity

Official Website octarinebio.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $5,850,000 · Series-A

    news.google.com

  2. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  3. Capital Raise

    Raised $4,350,000 · Round

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Octarine Bio.

Funding History

3 Rounds
Series-A equity · Apr 29, 2026
Series-A equity · Jan 22, 2026
Round equity · Nov 8, 2023

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts